Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ANACONDA-COVID-19: Anakinra plus optimized standard of care vs optimized standard of care in adults with worsening COVID-19 respiratory symptoms
2020-001734-36Phase 3Terminated
- Sponsor
- CHRU Tours
- Start
- Apr 2020
- Modality
- Cytokines & Interferons → Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial in coronavirus disease 2019 (COVID-19) comparing Anakinra + optimized standard of care with Optimized standard of care alone (2 arms). Started Apr 2020; status: terminated.
02
Drugs
anakinra
03
Conditions
coronavirus disease 2019 (COVID-19)
Beyond the preview
Go deeper on 2020-001734-36.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2020-001734-36.